Telbolife AB 2.5 Tablet contains Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 2.5mg, a triple-action therapy designed for effective hypertension management and overall cardiac health support. Telmisartan blocks angiotensin receptors to reduce blood pressure, Amlodipine relaxes blood vessels for improved circulation, and Bisoprolol regulates heart rate, providing comprehensive cardiovascular control.
This combination ensures enhanced therapeutic benefits and is highly trusted by prescribers, generating consistent demand. Patients benefit from better blood pressure control, reduced cardiovascular risk, and improved adherence to therapy.
For franchise partners, Telbolife AB 2.5 Tablet represents a high-demand cardiac care product with strong market acceptance. Its proven clinical performance and prescriber confidence make it a profitable addition to cardiovascular portfolios, helping expand business opportunities and attract loyal clients.
With its comprehensive cardiac protection, Telbolife AB 2.5 Tablet offers sustainable sales growth, making it an ideal choice for partners targeting hypertension and cardiac care markets.
Common side effects may include dizziness, fatigue, headache, palpitations, flushing, and mild swelling of the ankles. Less common side effects include hypotension, bradycardia, or gastrointestinal disturbances. Severe or persistent symptoms should be reported immediately to a healthcare professional.
Telbolife AB 2.5 Tablet is indicated for the management of essential hypertension, especially in patients who require combination therapy for optimal blood pressure control. It is also beneficial for patients with additional cardiovascular risk factors, including diabetes, coronary artery disease, or chronic kidney disease.
Telbolife AB 2.5 Tablet should be taken exactly as prescribed. Regular monitoring of blood pressure, heart rate, and kidney function is recommended. Do not discontinue therapy abruptly without consulting a doctor, as this may worsen cardiovascular conditions.
Store Telbolife AB 2.5 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.